|Last Price$7.39||Day Change (%)4.23%|
|Open Price$7.13||Day Change ($)0.30|
|Day Range7.05–7.51||52-Week Range2.92–7.51|
As of Wed 05/22/2013 12:22 PM EDT | USD
Tech Council of Maryland Announces Winners of 2013 Tech Awards at Annual Dinner and Celebration
Good day, ladies and gentlemen, and welcome to the Q2 2011 Vanda Pharmaceuticals , Incorporated Earnings Conference Call. My name is Erin, and I will be your operator for today. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. As a ...
We see opportunity as fleeing investors trigger an irrational sell-off.
Premature disappointment over the prospect of Vanda's sole drug has left investors with a compelling opportunity says Morningstar Opportunistic Investor's Stephen Ellis.
High levels of merger and acquisition activity will be the big theme of year for biotech, says Morningstar's Lauren Migliore.